In the second part of her Pharma Commerce video interview, Maggie McCullough, PolicyMap’s CEO, details what the company’s ...

Marketed as BNT327, the PD-L1xVEGF-A bispecific antibody has the potential to become what the involved parties believe is a ...

A cross-sectional study explores how full-benefit dual-eligible beneficiaries differ across MA plans with differing levels of ...

In the first part of her Pharma Commerce video interview, Maggie McCullough, PolicyMap’s CEO, explains how geospatial mapping ...

In the final part of his Pharma Commerce video interview, Scott Tillman, Logility’s senior vice president of innovation, ...

In a Pharmaceutical Executive feature, Gen Li, founder, CEO, Phesi, outlines five key challenges hindering investigator site selection in clinical trials—including unreliable performance predictions ...

Potential import taxes on pharma goods entering the United States continue to have effects on the industry in more ways than one. Tariffs galore officially commenced April 2, when President Trump ...

In the first part of his Pharma Commerce video interview, Scott Tillman, Logility’s senior vice president of innovation, ...

Alice Valder Curran outlines the steps manufacturers should take to better prepare for upcoming executive actions on drug ...

Exceptional CX significantly boosts engagement with healthcare professionals and consumers, leading to increased prescriptions, better market penetration, and improved health outcomes. Pharma ...